Table 1.
Clinico-pathological features of patient specimens
| Tumour | 1NM | Age | Gender | Dukes' stage | TNM stage | Differentiation | Vascular invasion |
2LNs harvested | LNs pos | Patient status | 3Follow-up time |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 001NM | 78 | F | B | pT3, pN0, pR0 | Poor | Absent | 15 | 0 | Well & symptom free | 48 |
| 002T | 002NM | 91 | M | B | pT3, pN0, pR0 | Moderate | Absent | 9 | 0 | Deceased (recurrence) | 35 |
| 003T | 003NM | 75 | M | C1 | pT3, pN1, pR0 | Poor | Absent | 10 | 3 | Well & symptom free) | 36 |
| 004T | 004NM | 74 | F | C1 | pT4, pN1, pR2 | Poor | Present | 11 | 3 | Deceased (recurrence) | <1 |
| 005T | 005NM | 76 | M | B | pT3, pN0, pR0 | Poor | Absent | 6 | 0 | Well & symptom free | 49 |
| - | 006NM | 69 | F | A | pT2, pN0, pR0 | Well | Absent | 11 | 0 | Well & symptom free | 40 |
| - | 007NM | 52 | M | C1 | pT3, pN1, pR0 | Poor | Absent | 23 | 3 | Well & symptom free | 48 |
| 008T | 008NM | 63 | F | C1 | pT4, pN0, pR0 | Poor | Absent | 10 | 0 | Deceased (recurrence) | 40 |
| 009T | 009NM | 68 | M | B | pT3, pN0, pR0 | Poor | Absent | 8 | 8 | Well & symptom free | 36 |
| 011T | 011NM | 77 | M | C1 | pT4,p N1, pR0 | Poor | Absent | 15 | 3 | Well & symptom free | 40 |
| 016T | 016NM | 61 | M | C2 | pT2, pN2, pR0 | Moderate | Present | 14 | 5 | Well & symptom free | 43 |
| 017T | 017NM | 65 | F | B | pT3, pN0, pR0 | Moderate | Absent | 14 | 0 | Well & symptom free | 39 |
| 020T | 020NM | 65 | F | B | pT3, pN0, pR0 | Poor | Absent | 12 | 0 | Well & symptom free | 36 |
| 021T | 021NM | 72 | M | B | pT4, pN1, pR0 | Moderate | Present | 5 | 1 | Well & symptom free | 28 |
| 023T | 023NM | 59 | M | B | pT3, pN0, pR0 | Moderate | Absent | 10 | 0 | Well & symptom free | 20 |
| 024T | 024NM | 41 | F | C2 | pT4, pN1, pRx | Well | Absent | 15 | 2 | Deceased (recurrence) | 30 |
| 025T | - | 82 | M | B | pT4, pN0, pMx, pRx | Poor | Absent | 7 | 0 | Deceased (recurrence) | 13 |
| 026T | 026NM | 76 | F | A | pT2, pN0, pR0 | Moderate | Absent | 5 | 0 | Deceased (recurrence) | 36 |
| 028T | 028NM | 86 | F | C1 | pT3, pN1, pR0 | Moderate | Absent | 12 | 0 | Well & symptom free | 36 |
| 029T | 029NM | 71 | F | B | pT3, pN0, pR0 | Well | Absent | 32 | 0 | Well & symptom free | 36 |
| 031T | 031NM | 82 | M | C2 | pT3, pN2, pR0 | Poor | Present | 11 | 3 | Well & symptom free | 36 |
| 032T | 032NM | 69 | F | B | pT4, pN0, pR0 | Moderate | Absent | 11 | 0 | Well & symptom free | 23 |
| 033T | 033NM | 72 | M | C1 | pT4, pN1, pR0 | Moderate | Absent | 8 | 1 | Well & symptom free | 22 |
| 034T | 034NM | 58 | M | C1 | pT4, pN1, pR0 | Moderate | Absent | 5 | 3 | Well & symptom free | 25 |
| - | 035NM | 77 | F | B | pT3, pN0, pR0 | Poor | Absent | 7 | 0 | Well & symptom free | 25 |
| 036T | - | 81 | F | B | pT3, pN0, pR0 | Moderate | Absent | 13 | 0 | Well & symptom free | 21 |
| 037T | 037NM | 77 | F | B | pT3, pN0, pR0 | Well | Absent | 7 | 0 | Well & symptom free | 19 |
| 038T | 038NM | 76 | F | A | pT2, pN1, pR0 | Poor | Absent | 5 | 1 | Well & symptom free | 20 |
| 039T | 039NM | 75 | F | B | pT3, pN0, pR0 | Moderate | Absent | 16 | 0 | Well & symptom free | 23 |
| 2012T | 2012NM | 62 | M | C1 | pT3, pN1, pR0 | Poor | Present | 18 | 3 | Well & symptom free | 20 |
| 2018T | 2018NM | 83 | F | A | pT1, pN0, pR0 | Moderate | Absent | 6 | 0 | Deceased (unrelated) | 2 |
| 2022T | 2022NM | 56 | M | B | pT3, pN0, pR0 | Well | Present | 20 | 0 | Well & symptom free | 20 |
| 2044T | 2044NM | 82 | M | A | pT2, pN0, pR0 | Moderate | Absent | 10 | 0 | Well & symptom free | 21 |
| - | 2080NM | 72 | F | A | pT2, pN0, pR0 | Moderate | Absent | 5 | 0 | Well & symptom free | 21 |
| 2084T | - | 38 | M | B | ypT3, ypN0, ypR0 | Poor | Absent | 10 | 0 | Well & symptom free | 20 |
| 2085T | 2085NM | 78 | F | C1 | pT3, pN1, pR0 | Moderate | Absent | 11 | 1 | Deceased (unrelated) | <1 |
1NM = normal mucosa; 2LN = lymph node; 3follow-up time in months